Research Collaboration and Outcome Measures of Interventional Clinical Trial Protocols for COVID-19 in China
Background: Research collaboration of registered clinical trials for Coronavirus Disease 2019 (COVID-19) remains unclear. This study aimed to analyze research collaboration and distribution of outcome measures in registered interventional clinical trials (ICTs) of COVID-19 conducted in China.Methods...
Main Authors: | Ya Gao, Kelu Yang, Ming Liu, Yamin Chen, Shuzhen Shi, Fengwen Yang, Jinhui Tian |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2020-09-01
|
Series: | Frontiers in Public Health |
Subjects: | |
Online Access: | https://www.frontiersin.org/article/10.3389/fpubh.2020.554247/full |
Similar Items
-
Establishing a core outcome set for neurogenic bladder trials: study protocol for a scoping review and Delphi surveys
by: Yan Zhang, et al.
Published: (2022-06-01) -
Research methodology and characteristics of journal articles with original data, preprint articles and registered clinical trial protocols about COVID-19
by: Mahir Fidahic, et al.
Published: (2020-06-01) -
The study protocol for a non-randomized controlled clinical trial using a genotype-guided strategy in a dataset of patients who undergone percutaneous coronary intervention with stent
by: Cristina Lucía Dávila-Fajardo, et al.
Published: (2017-02-01) -
The Pipeline of Therapeutics Testing During the Emergency Phase of the COVID-19 Outbreak
by: Marco Canevelli, et al.
Published: (2020-09-01) -
Therapeutic Role of Neutralizing Antibody for the Treatment against SARS-CoV-2 and Its Emerging Variants: A Clinical and Pre-Clinical Perspective
by: Manojit Bhattacharya, et al.
Published: (2022-09-01)